Subsequent studies demonstrated that the c-MYC gene, coupled with the immunoglobulin μ or κ enhancer in transgenic mice, was highly leukemogenic and resulted in the development of fatal B-cell lymphomas [6]. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.